Surgical mesh is a medical device constructed using synthetic materials or animal tissue and used to provide extra support to weak or damaged tissue. Surgical polypropylene mesh is widely adopted in the market due to its stability, durability, low infection risk, and high mechanical strength. Non-absorbable surgical mesh has wide applicability in various procedures such as prosthetic hernioplasty, reconstruction of the chest wall, reinforcement of fascial tissue, etc. Some factors, such as the growing number of hernia cases, increasing awareness about the benefits of implanting mesh material in corrective surgeries, technological advancements in the nature of surgical mesh, and a rising number of risk factors, such as obesity and changing lifestyle patterns, are driving the growth of the surgical polypropylene mesh market globally.
The global surgical polypropylene mesh market is categorized on the basis of applications such as hernia repair, urinary incontinence, pelvic organ prolapse, and other applications. It is observed that, in the base year 2016, hernia repair was the major revenue-contributing segment because the demand for hernia repair surgical procedures has increased in the market. In recent years, the approach to hernia repair procedures has shifted from autogenous tissue repair to the use of biological and synthetic mesh. Hernias have a higher rate of recurrence, and thus surgical mesh is preferably used to strengthen hernia repairs and reduce the risk of recurrence. An increase in the prevalence of hernias, rising awareness about surgery, and technological advancements in the surgical mesh are the prime factors assisting the growth of the hernia repair mesh market globally.
In recent years, North America has dominated the global surgical polypropylene mesh market in terms of revenue, and it is anticipated that it will continue to do so during the forecast period of 2017–2025. Some factors, such as the higher cost of the mesh, the wide availability of polypropylene mesh, the well-developed healthcare infrastructure, and the increase in the number of target populations, are assisting the growth of the surgical polypropylene mesh market in North America. However, Asia-Pacific is expected to show profitable market growth during the forecast period. Improving healthcare infrastructure, growing healthcare awareness, and developing economic conditions would drive market growth in Asia Pacific.
The surgical polypropylene mesh market is competitive, and a large number of players are present in the market. The market is currently dominated by a few manufacturers, such as Altaylar Medical Ltd., Atrium Inc., B. Braun Melsungen AG, Ethicon Inc., C. R. Bard Inc., and others.
This report offers the following:
- An overview of the global surgical polypropylene meshes market
- development assessment for the period 2015–2025, with a CAGR of 3.8% during 2017–2025.
- Qualitative information such as market drivers, opportunities, and challenges
- in-depth information about market segmentation based on approvals, product launches, and anticipated market dynamics.
- A general overview of the market scenario
- Company profiles provide an overview of the key players operating in the surgical polypropylene mesh market.